Skip to main content
613 Assessing the prevalence of hepatobiliary involvement in cystic fibrosis using European Society for Paediatric Gastroenterology Hepatology and Nutrition and North American Society For Pediatric Gastroenterology, Hepatology and Nutrition classification
610 Gaps between new hepatobiliary screening guidelines and clinical practice in cystic fibrosis.
109 Chemical development of dual species–host and Aspergillus fumigatus–sphingosine-1-phosphate lyase inhibitors as therapeutic strategy in cystic fibrosis.
813 Decreasing sweat chloride quantity not sufficient rates.
148 Exploring dual targeting of host and microbial sphingosine-1-phosphate lyase as antimicrobial strategy in cystic fibrosis.
483 Describing the oropharyngeal microbiome in children with cystic fibrosis transmembrane regulator related metabolic syndrome.
77 Improving transition from pediatric to adult cystic fibrosis care: A quality improvement initiative.
323 It's time to be blunt—a deeper investigation of attitudes and usage of marijuana, cannabidiol, and cigarettes in the cystic fibrosis community.
521: Dual targeting of host and fungal sphingosine-1-phosphate lyase as antifungal strategy in cystic fibrosis.
271: Loss of control, shifts in illness identity, and perceived vulnerability underlie traumatic illness–related experiences in patients with cystic fibrosis.